Cargando…

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression

[18F]-FDOPA is a labeled amino acid (AA) analog used for positron emission tomography (PET) which is gaining increasing interest in the evaluation of brain tumors (BT). The AA-transporter LAT1 has been shown to be involved in [18F]-FDOPA uptake. The aim of this study was to determine whether the [18...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dadone-Montaudié, Bérengère, Ambrosetti, Damien, Dufour, Maxime, Darcourt, Jacques, Almairac, Fabien, Coyne, John, Virolle, Thierry, Humbert, Olivier, Burel-Vandenbos, Fanny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609741/ https://www.ncbi.nlm.nih.gov/pubmed/28937983 http://dx.doi.org/10.1371/journal.pone.0184625

Ejemplares similares

Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers
por: Papin-Michault, Caroline, et al.
Publicado: (2016)

Superficial CD34-positive Fibroblastic Tumour: Unique Subungual Presentation with Confounding Clinical Findings Resembling Fibrokeratoma-like Bowen’s Disease
por: PERRIN, Christophe, et al.
Publicado: (2021)

AGAP3 : A novel BRAF fusion partner in pediatric pancreatic‐type acinar cell carcinoma
por: Paoli, Charlotte, et al.
Publicado: (2022)

Development and validation of a radiomic model for the diagnosis of dopaminergic denervation on [18F]FDOPA PET/CT
por: Comte, Victor, et al.
Publicado: (2022)

Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth
por: Fareh, Mohamed, et al.
Publicado: (2017)

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma
por: Ambrosetti, Damien, et al.
Publicado: (2018)

CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3
por: Turchi, Laurent, et al.
Publicado: (2023)

Optimization of time frame binning for FDOPA uptake quantification in glioma
por: Girard, Antoine, et al.
Publicado: (2020)

Primal-dual for classification with rejection (PD-CR): a novel method for classification and feature selection—an application in metabolomics studies
por: Chardin, David, et al.
Publicado: (2021)

Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author’s reply
por: Burel-Vandenbos, Fanny, et al.
Publicado: (2020)

The effects of molar activity on [(18)F]FDOPA uptake in patients with neuroendocrine tumors
por: Stormezand, Gilles N., et al.
Publicado: (2021)

Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase
por: Saurty-Seerunghen, Mirca S., et al.
Publicado: (2022)

Adrenal tracer uptake by (18)F-FDOPA PET/CT in patients with pheochromocytoma and controls
por: Noordzij, Walter, et al.
Publicado: (2019)

Cerebral [(18)F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits
por: Schalbroeck, Rik, et al.
Publicado: (2021)

Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection
por: Cardot-Leccia, Nathalie, et al.
Publicado: (2020)

An automatic analysis framework for FDOPA PET neuroimaging
por: Nordio, Giovanna, et al.
Publicado: (2023)

Enzyme inhibition of dopamine metabolism alters 6-[(18)F]FDOPA uptake in orthotopic pancreatic adenocarcinoma
por: Tuomela, Johanna, et al.
Publicado: (2013)

MGMT Promoter Methylation and IDH1 Mutations Do Not Affect [(18)F]FDOPA Uptake in Primary Brain Tumors
por: Cimini, Andrea, et al.
Publicado: (2020)

Effects of Carbidopa Premedication on (18)F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis
por: Bros, Marie, et al.
Publicado: (2021)

Additive Value of Dynamic FDOPA PET/CT for Glioma Grading
por: Girard, Antoine, et al.
Publicado: (2021)

Dynamic (18)F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?
por: Zaragori, Timothée, et al.
Publicado: (2021)

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
por: Spalato-Ceruso, Mariella, et al.
Publicado: (2022)

MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction
por: Di Mauro, Ilaria, et al.
Publicado: (2020)

Age-related schwannomatosis with potential exosome-mediated contribution to prostate hyperplasia: a case report and mini-review
por: Chignon-Sicard, Bérengère, et al.
Publicado: (2019)

y+LAT1 and y+LAT2 contribution to arginine uptake in different human cell models: Implications in the pathophysiology of Lysinuric Protein Intolerance
por: Rotoli, Bianca Maria, et al.
Publicado: (2019)

High-grade childhood intra-parenchymal brain tumor clustering with ATRT and expanding the cancer spectrum related to inherited SMARCE1 truncating variations
por: Forest, Fabien, et al.
Publicado: (2022)

Nucleophilic Synthesis of 6-l-[(18)F]FDOPA. Is Copper-Mediated Radiofluorination the Answer?
por: Krasikova, Raisa N.
Publicado: (2020)

Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of Parkinsonian disorders
por: Stormezand, Gilles N., et al.
Publicado: (2020)

(18)F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma
por: Tepede, Aisha A, et al.
Publicado: (2020)

Comparison of 6-[(18)F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
por: Michler, Enrico, et al.
Publicado: (2021)

Automated Data Quality Control in FDOPA brain PET Imaging using Deep Learning
por: Pontoriero, Antonella D., et al.
Publicado: (2021)

Pharmacokinetic Modeling of (18)F-FDOPA PET in the Human Brain for Early Parkinson’s Disease
por: Buratachwatanasiri, Wirunpatch, et al.
Publicado: (2021)

The Inactivation of Arx in Pancreatic α-Cells Triggers Their Neogenesis and Conversion into Functional β-Like Cells
por: Courtney, Monica, et al.
Publicado: (2013)

Characteristics of (18)F-FDG and (18)F-FDOPA PET in an 8-year-old neutered male Yorkshire Terrier dog with glioma: long-term chemotherapy using hydroxyurea plus imatinib with prednisolone and immunoreactivity for PDGFR-β and LAT1
por: Yun, Taesik, et al.
Publicado: (2021)

Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
por: Emsen, Berivan, et al.
Publicado: (2020)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma
por: Liu, Yen-Lin, et al.
Publicado: (2016)

Usefulness of (18)F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature
por: Somme, François, et al.
Publicado: (2020)

A potential biomarker for treatment stratification in psychosis: evaluation of an [(18)F] FDOPA PET imaging approach
por: Veronese, Mattia, et al.
Publicado: (2020)

Accurate detection of intracranial extension of jugulotympanic paraganglioma by [(18)F]FDOPA-PET/CT comparing to MRI
por: Araghi, Zahra Jamshidi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9i740q4naqt0hu3fnmm8a0nubj